Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis.
Autoimmune Hepatitis-like reaction developing in a patient treated with Interferon beta 1a.
Gpr126 is essential for peripheral nerve development and myelination in mammals.
Glatiramer Acetate 40 mg/mL in Relapsing-Remitting Multiple Sclerosis: A Review.
Anti-JCV antibody levels in serum or plasma further define risk of natalizumab-associated PML.
Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial.
Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report.
Autoimmunity in visual loss.
The N-terminal pro-brain natriuretic peptide as a marker of mitoxantrone-induced cardiotoxicity in multiple sclerosis patients.
Paraoxonase 1 activity in multiple sclerosis patients during mitoxantrone therapy.
Genmab announces results of ofatumumab Phase II study in multiple sclerosis
Combination therapy with mitoxantrone and plasma exchange in aggressive relapsing remitting multiple sclerosis: A preliminary clinical study.
Dimethyl fumarate inhibits integrin α4 expression in multiple sclerosis models.
Role of regulatory b cells in neuroimmunologic disorders.
Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS.
Are natural killer cells involved in multiple sclerosis etiology? Evidences from NKp46/NCR1 receptor modulation in an observational study.
Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Monoclonal antibodies in MS: mechanisms of action.
Monomethyl fumarate augments NK cell lysis of tumor cells through degranulation and the upregulation of NKp46 and CD107a.
Tolerability and Pulmonary Pharmacodynamic Effects During Treatment Initiation of Once-Daily Oral Fingolimod in Subjects With Moderate Asthma.
Mitoxantrone and ametantrone induce interstrand cross-links in DNA of tumour cells.
Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development.
Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.
Interferon beta-1a long-term therapy related to pulmonary arterial hypertension in multiple sclerosis patients.
Multiple sclerosis: A lifestyle disease?

Pages